Clinical Policy Annual Review (July 2025)
The following clinical policies were recently adopted by Meridian. The criteria within these policies may impact the prior authorization process. You can view these policies once they are in effect on our Clinical & Payment Policies page. These policies go into effect August 22, 2025.
- CP.MP.126 - Sacroiliac Joint Fusion
- CP.MP.12 - Vagus Nerve Stimulation
- CP.MP.134 - Evoked Potential Testing
- CP.MP.152 - Measurement of Serum 1,25-dihydroxyvitamin D
- CP.MP.180 - Implantable Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea
- CP.MP.106 - Endometrial Ablation
- CP.MP.98 - Urodynamic Testing
- CP.MP.38 - Ultrasound in Pregnancy
- CP.MP.121 - Homocysteine Testing
- CP.MP.153 - Helicobacter Pylori Serology Testing
- CP.MP.242 - Pulmonary Function Testing
- CP.MP.210 - Repair of Nasal Valve Compromise
- CP.MP.150 - Phototherapy for Neonatal Hyperbilirubinemia
- CP.MP.154 - Thyroid Hormones and Insulin Testing in Pediatrics
The following clinical policies have undergone an annual review with some added criteria requirements that may impact the prior authorization process. Please see the revision log within each policy to review the changes. You can view these updated policies once they are in effect on our Clinical & Payment Policies page. These policies go into effect August 22, 2025.
- CC.PP.206 - SNF Leveling
- CP.MP.132 - Heart-Lung Transplant
- CP.MP.58 - Intestinal and Multivisceral Transplants
- CP.MP.87 - Therapeutic Utilization of Inhaled Nitric Oxide
- CP.MP.137 - Fecal Incontinence Treatments
- CP.MP.51 Reduction Mammoplasty and Gynecomastia Surgery
- MI.CP.MP.504 - ReliZorb (retired)